Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma

OBJECTIVE: Previous studies have confirmed the biglycan (BGN) as a core gene in stomach adenocarcinoma (STAD). Present study aimed at conducting further investigations to reveal the potential function of BGN in STAD. METHODS: The mRNA and protein expressions of BGN in STAD were firstly evaluated, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Changming, Cheng, Chunfa, Shao, Qinshu, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290488/
https://www.ncbi.nlm.nih.gov/pubmed/34295178
http://dx.doi.org/10.2147/IJGM.S321641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290488/
https://www.ncbi.nlm.nih.gov/pubmed/34295178
http://dx.doi.org/10.2147/IJGM.S321641

Ejemplares similares